The Lupus Ontario Web site is provided as a source of information about Lupus Ontario, lupus the disease, as well as activities of interest to people with lupus, their families and friends. Information found on the website or accessed through the website is not intended to replace the advice from and important relationship with your physician. Your physician should be your primary resource for information about lupus, its diagnosis and treatment. Lupus Ontario offers its Web site with the hope that the quality of life of people with lupus will improve through a greater understanding of lupus and its treatment.
Please consider supporting the work of Lupus Ontario on lupus sufferers' behalf by donating to research.
Please note: Not all questions may be answered or posted. Those questions that are answered will be E-mailed to the originator of the question, and will be posted on the Web for others to learn from. No names will be used. For answers to previous questions please browse our Expert Q & A's Archive
Dr. Janet Pope is an Associate Professor of Medicine in the Division of Rheumatology and also Epidemiology and Biostatistics at the University of Western Ontario, London, Ontario, Canada. She obtained her MD, and Fellowship in Internal Medicine at the University of Western Ontario. Then her Fellowship in Rheumatology and Masters of Public Health was acquired at Boston University. She completed a Canadian Arthritis Society Research Fellowship in London, Ontario in scleroderma and then became a member of the Division of Rheumatology. She is currently Program Director in Rheumatology, sits on 5 Advisory Boards and is a member of the Scleroderma Clinical Trials Consortium, Vice President of CaNIOS (Canadian Network for Improved Outcomes in SLE) and on the executive of the Canadian Rheumatology Association and the Canadian Rheumatology Research Consortium. Research includes epidemiologic studies in scleroderma including outcome measurement, clinical trials and disease manifestations in scleroderma. She also has an interest in hormonal changes in rheumatic diseases and holds grants in the study of diseases such as scleroderma, RA, and SLE. She has published over 50 articles and 8 chapters and several Cochrane meta-analysis reviews.
